Cargando…

Translational nanoparticle engineering for cancer vaccines

Conventional cancer treatments remain insufficient to treat many therapy-resistant tumors.(1) Cancer vaccines attempt to overcome this resistance by activating the patient's immune system to eliminate tumor cells without the toxicity of systemic chemotherapy and radiation. Nanoparticles (NPs) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grippin, Adam J., Sayour, Elias J., Mitchell, Duane A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665077/ https://www.ncbi.nlm.nih.gov/pubmed/29123947 http://dx.doi.org/10.1080/2162402X.2017.1290036

Ejemplares similares

2422: Magnetic nanoparticles facilitate tracking of dendritic cells for treatment of malignant brain tumors
por: Grippin, Adam, et al.
Publicado: (2018)

2173 RNA-nanoparticles to enhance and track dendritic cell migration
por: Grippin, Adam J., et al.
Publicado: (2018)

IMMU-13. CUSTOMIZABLE MULTI-LAMELLAR RNA-NANOPARTICLES FOR PEDIATRIC GLIOMA
por: Mendez-Gomez, Hector, et al.
Publicado: (2021)

Manipulation of Innate and Adaptive Immunity through Cancer Vaccines
por: Sayour, Elias J., et al.
Publicado: (2017)

Emerging trends in immunotherapy for pediatric sarcomas
por: Dyson, Kyle A., et al.
Publicado: (2019)

Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes
por: Sayour, Elias J., et al.
Publicado: (2018)

Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics
por: Sayour, Elias J, et al.
Publicado: (2015)

Systemic activation of antigen-presenting cells via RNA-loaded nanoparticles
por: Sayour, Elias J., et al.
Publicado: (2016)

Immunotherapy for Pediatric Brain Tumors
por: Sayour, Elias J., et al.
Publicado: (2017)

COVD-02. ADAPTING RNA-NANOPARTICLE VACCINES FROM GLIOBLASTOMA TO SARS-COV-2
por: Mendez-Gomez, Hector, et al.
Publicado: (2020)

Contemporary RNA Therapeutics for Glioblastoma
por: Melnick, Kaitlyn, et al.
Publicado: (2021)

IMMU-06. SYSTEMIC MRNA VACCINES RESET IMMUNOGENICITY AGAINST DIFFUSE MIDLINE GLIOMA
por: McGuiness, James, et al.
Publicado: (2023)

Direct imaging of RNA loaded lipid-nanoparticles’ self assembly and cellular expression for cancer immunotherapy and RNA-based vaccines
por: Ashbrook, Jewel, et al.
Publicado: (2022)

Vaccine Therapies for Cancer: Then and Now
por: Morse, Michael A., et al.
Publicado: (2021)

CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors
por: Jin, Linchun, et al.
Publicado: (2019)

Optimizing T Cell-Based Therapy for Glioblastoma
por: Karachi, Aida, et al.
Publicado: (2021)

Engineering precision nanoparticles for drug delivery
por: Mitchell, Michael J., et al.
Publicado: (2020)

Nanoparticles in Clinical Translation for Cancer Therapy
por: Mundekkad, Deepa, et al.
Publicado: (2022)

Translating tissue engineering technology platforms into cancer research
por: Hutmacher, Dietmar W, et al.
Publicado: (2009)

Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling
por: Dastmalchi, Farhad, et al.
Publicado: (2019)

Proton therapy for pediatric diencephalic tumors
por: Grippin, Adam J., et al.
Publicado: (2023)

Targeted Cancer Immunotherapy: Nanoformulation Engineering and Clinical Translation
por: Yu, Meihua, et al.
Publicado: (2022)

Evaluation of phase I clinical trial designs for combinational agents along with guidance based on simulation studies
por: Wang, Shu, et al.
Publicado: (2022)

Evolution and Revolution of Imaging Technologies in Neurosurgery
por: OGANDO-RIVAS, Elizabeth, et al.
Publicado: (2022)

Targeting Engineered Nanoparticles for Breast Cancer Therapy
por: Ganesan, Kumar, et al.
Publicado: (2021)

New opportunities for RGD-engineered metal nanoparticles in cancer
por: Qin, Wei, et al.
Publicado: (2023)

Advanced Robotics to Address the Translational Gap in Tendon Engineering
por: Sander, Iain L., et al.
Publicado: (2022)

Translational Application of 3D Bioprinting for Cartilage Tissue Engineering
por: McGivern, Sophie, et al.
Publicado: (2021)

CAR T Cell Locomotion in Solid Tumor Microenvironment
por: Nguyen, Duy T., et al.
Publicado: (2022)

Tissue engineering of the gastrointestinal tract: the historic path to translation
por: Collier, Claudia A., et al.
Publicado: (2022)

The Potential Translational Applications of Nanoparticles in Endodontics
por: Wong, Jasmine, et al.
Publicado: (2021)

Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation
por: Renukaradhya, Gourapura J., et al.
Publicado: (2015)

Current and future nanoparticle vaccines for COVID-19
por: Vu, Mai N., et al.
Publicado: (2021)

Engineering Cell Surfaces with Polyelectrolyte Materials for Translational Applications
por: Zhang, Peipei, et al.
Publicado: (2017)

Challenges in translating vascular tissue engineering to the pediatric clinic
por: Duncan, Daniel R, et al.
Publicado: (2011)

Engineering Organ-on-a-Chip to Accelerate Translational Research
por: Ko, Jihoon, et al.
Publicado: (2022)

Cellular Cancer Immunotherapy Development and Manufacturing in the Clinic
por: Fenton, Graeme A., et al.
Publicado: (2023)

Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology
por: Foster, Jessica B., et al.
Publicado: (2023)

Engineered nanoparticles induce cell apoptosis: potential for cancer therapy
por: Ma, Dan-Dan, et al.
Publicado: (2016)

Nanoparticles in tissue engineering: applications, challenges and prospects
por: Hasan, Anwarul, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1t2fbgla4cefvohm7mqh0s79q0